Amlodipine PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified pharmaceutical company offering a Amlodipine PCD pharma franchise across India. Our portfolio spans 34 Amlodipine formulations in Tablet form, backed by consistent quality and monopoly-based distribution rights for our franchise partners.

What is Amlodipine?

Amlodipine is a long-acting dihydropyridine calcium-channel blocker that relaxes vascular smooth muscle by limiting calcium entry, widening blood vessels and lowering blood pressure while easing the heart's workload. Its long half-life allows once-daily dosing. Its profile is documented on PubChem.

Therapeutic Applications

Amlodipine tablets are prescribed for hypertension and for chronic stable and vasospastic (Prinzmetal) angina, both as monotherapy and in fixed-dose combinations with ACE inhibitors, ARBs, beta-blockers or statins. It is prescribed by cardiologists, general physicians, diabetologists and nephrologists.

Why Amlodipine is a High-Potential Molecule for Distributors

Hypertension is among the most prevalent chronic conditions in India and is managed lifelong, making amlodipine one of the highest-volume cardiac molecules on the market. Its central role in fixed-dose combination therapy means a distributor can build an entire cardio-diabetic range around it, and 34 formulations give the flexibility to match almost any prescriber's preferred combination. Daily, lifelong dosing translates into exceptionally reliable repeat orders.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers district and state-wise monopoly rights, WHO-GMP certified and DCGI-approved manufacturing, attractive promotional inputs, and the backing of a network of 1000+ franchise partners. Our transparent supply and billing model helps you build a profitable, protected business in your territory.

References

1. PubChem — Amlodipine
2. MedlinePlus — High Blood Pressure
3. PubMed — Amlodipine literature